ZA793667B - N-arylsulfonylpyrroles,their preparation,and therapeutic agents containing these compounds - Google Patents

N-arylsulfonylpyrroles,their preparation,and therapeutic agents containing these compounds

Info

Publication number
ZA793667B
ZA793667B ZA00793667A ZA793667A ZA793667B ZA 793667 B ZA793667 B ZA 793667B ZA 00793667 A ZA00793667 A ZA 00793667A ZA 793667 A ZA793667 A ZA 793667A ZA 793667 B ZA793667 B ZA 793667B
Authority
ZA
South Africa
Prior art keywords
arylsulfonylpyrroles
compounds
preparation
therapeutic agents
agents containing
Prior art date
Application number
ZA00793667A
Other languages
English (en)
Inventor
D Lenke
J Bliesener
C Mueller
K Geiss
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA793667B publication Critical patent/ZA793667B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00793667A 1978-07-20 1979-07-19 N-arylsulfonylpyrroles,their preparation,and therapeutic agents containing these compounds ZA793667B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782831850 DE2831850A1 (de) 1978-07-20 1978-07-20 N-arylsulfonylpyrrole, ihre herstellung und diese enthaltende therapeutische mittel

Publications (1)

Publication Number Publication Date
ZA793667B true ZA793667B (en) 1980-07-30

Family

ID=6044858

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00793667A ZA793667B (en) 1978-07-20 1979-07-19 N-arylsulfonylpyrroles,their preparation,and therapeutic agents containing these compounds

Country Status (3)

Country Link
JP (1) JPS5517382A (xx)
DE (1) DE2831850A1 (xx)
ZA (1) ZA793667B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5929442A (ja) * 1982-08-10 1984-02-16 Mitsubishi Electric Corp 半導体装置用リ−ドフレ−ム
ES2295816T3 (es) 2003-01-14 2008-04-16 Arena Pharmaceuticals, Inc. Derivados arilo y heteroarilo 1,2,3-trisustituidos como moduladores del metabolismo, y profilaxis y tratamiento de transtornos relacionados con los mismos, tales como la diabetes y la hiperglucemia.
EP1927594A1 (en) * 2003-01-14 2008-06-04 Arena Pharmaceuticals, Inc. 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
CN103539791B (zh) 2010-09-22 2017-01-11 艾尼纳制药公司 Gpr119 受体调节剂和对与其相关的障碍的治疗
CN107405332A (zh) 2015-01-06 2017-11-28 艾尼纳制药公司 治疗与s1p1受体有关的病症的方法
US10301262B2 (en) 2015-06-22 2019-05-28 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders
EP3582772A1 (en) 2017-02-16 2019-12-25 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis

Also Published As

Publication number Publication date
DE2831850A1 (de) 1980-02-07
JPS5517382A (en) 1980-02-06

Similar Documents

Publication Publication Date Title
PH15198A (en) Therapeutic agents
ZA796708B (en) Therapeutic agents
ZA80298B (en) Therapeutic agents
PH15463A (en) Improved unit dosage form
EG16606A (en) Therapeutic agents
DE2963145D1 (en) Fungicidal acylanilide compounds, their preparation, compositions containing them and their use
DE2960024D1 (en) Substituted diphenylmethyl-imidazoles, their preparation and medicaments containing them
ZA792390B (en) Therapeutic agents
ZA793667B (en) N-arylsulfonylpyrroles,their preparation,and therapeutic agents containing these compounds
GB2013181B (en) Therapeutic agents
DE2960021D1 (en) Acyloxy-2-butenes, their preparation and their use for the preparation of 4-acetoxytiglinaldehyde
DE2962567D1 (en) N-phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them
ZA794295B (en) Beta-lamtam compounds,their preparation and use
ZA796759B (en) Dihydropyridazinones, their preparation and therapeutic agents containing these compounds
GB2019836B (en) Therapeutic agents
ZA813966B (en) Novel dihydropyridaziones,their preparation and therapeutic agents containing these compounds
GB2028132B (en) Antifibrotic substance p-1894b
JPS5527168A (en) Drug composition
GB2011890B (en) Therapeutic agents
GB2047691B (en) Therapeutic agents
GB2053910B (en) Pyridylaminotriazole therapeutic agents
JPS5540677A (en) Medical composition
IL57423A (en) Furonaphthyridine compounds and their preparation
GB2013179B (en) Therapeutic agents
GB2011891B (en) Therapeutic agents